Short name: P717, generic name: Gd-DOTA-dextran, central moiety: Gd
A Gd-DOTA-dextran derivative slow-clearance blood pool agent (MRIcontrast agent) under development (preclin., Guerbet SA).
The France-based Guerbet Group is highly specialized in contrast media for medical imaging. Its strategic goal is to be a key player in this market. Products include Dotarem (Magnetic Resonance Imaging) and Xenetix (X-ray Imaging).